Get Live Data

The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE IMMUNOGEN, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.00
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.044 (5.023%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.876
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE IMMUNOGEN, INC.

13 Feb 2024 07:00

RNS Number : 9464C
BioPharma Credit PLC
13 February 2024
 

BioPharma Credit PLC

13 February 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE ImmunoGen, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 12 February 2024 by AbbVie Inc. ("AbbVie") regarding the completion of its acquisition of ImmunoGen, Inc. ("IMGN") (such acquisition, the "Transaction"). AbbVie and IMGN had previously announced the entering into of a definitive agreement regarding the Transaction on Thursday 30 November 2023.

 

The Company announced on 11 April 2023 an investment in a senior secured loan to IMGN of up to US$62.5 million in up to two tranches. The Company had previously funded the first tranche representing a US$37.5 million investment, which was prepaid upon the closing of the Transaction. The Company received US$50.6 million in total, including $13.1 million of accrued interest, additional consideration, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRGPUUCPUPCUQW
12345678910
Date   Source Headline
1st Aug 202311:29 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSSTATEMENT RE REATA PHARMACEUTICALS
21st Jul 20234:00 pmRNSNet Asset Value(s)
21st Jul 202311:30 amRNSUPDATE ON INVESTMENT
18th Jul 20237:00 amRNSUPDATE ON INVESTMENT
11th Jul 20236:15 pmRNSTransaction in Own Shares
10th Jul 20236:15 pmRNSTransaction in Own Shares
3rd Jul 20231:34 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSUpdate on Investment
30th Jun 20236:15 pmRNSTransaction in Own Shares
29th Jun 20236:15 pmRNSTransaction in Own Shares
26th Jun 20236:15 pmRNSTransaction in Own Shares
22nd Jun 20236:15 pmRNSTransaction in Own Shares
21st Jun 20234:00 pmRNSNet Asset Value(s)
20th Jun 20236:15 pmRNSTransaction in Own Shares
15th Jun 20236:15 pmRNSTransaction in Own Shares
13th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20237:00 amRNSUPDATE ON INVESTMENT
7th Jun 20236:15 pmRNSTransaction in Own Shares
6th Jun 20236:15 pmRNSTransaction in Own Shares
1st Jun 202312:04 pmRNSTotal Voting Rights
31st May 20236:15 pmRNSTransaction in Own Shares
30th May 20233:08 pmRNSResult of AGM
26th May 20236:15 pmRNSTransaction in Own Shares
25th May 20236:15 pmRNSTransaction in Own Shares
24th May 20236:15 pmRNSTransaction in Own Shares
23rd May 20236:15 pmRNSTransaction in Own Shares
23rd May 20234:00 pmRNSNet Asset Value(s)
19th May 20236:15 pmRNSTransaction in Own Shares
19th May 20237:00 amRNSUpdate on Investment
18th May 20236:15 pmRNSTransaction in Own Shares
16th May 20233:40 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSNEW INVESTMENT OF UP TO US$137.5 MILLION
9th May 20236:15 pmRNSTransaction in Own Shares
5th May 20236:15 pmRNSTransaction in Own Shares
2nd May 20236:15 pmRNSTransaction in Own Shares
2nd May 20231:26 pmRNSTotal Voting Rights
28th Apr 20236:15 pmRNSTransaction in Own Shares
25th Apr 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Apr 20237:00 amRNSDividend Declaration
19th Apr 20237:00 amRNSNEW INVESTMENT OF UP TO US$180.0 MILLION
14th Apr 20234:30 pmRNSNotice of AGM
11th Apr 20237:00 amRNSNEW INVESTMENT OF UP TO US$62.5 MILLION
29th Mar 202311:27 amRNSDirector/PDMR Shareholding
24th Mar 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Mar 20237:10 amRNSAppointment of New Director
22nd Mar 20237:05 amRNSDividend Declaration
22nd Mar 20237:00 amRNSAnnual Financial Report
13th Mar 20237:00 amRNSSTATEMENT REGARDING SILICON VALLEY BANK
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.